search
Back to results

Prospective Randomized Trial of Stratafix vs. Vicryl in Total Hip Arthroplasty.

Primary Purpose

Wound; Hip

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
STRATIFIX
VICRYL
Sponsored by
The Cleveland Clinic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Wound; Hip focused on measuring barbed suture, knoteless suture, closure, wound, time, total hip arthroplasty

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Males and females, between the ages of 18 to 80 years at the time of signing the informed consent document.
  2. Understand and voluntarily sign an informed consent document prior to any study-related assessments/procedures are conducted.
  3. Able to adhere to the study visit schedule and other protocol requirements.
  4. Able to fluently speak and understand the local language
  5. If female, is non-pregnant (negative pregnancy test results at the baseline/randomization visit) and non-lactating.
  6. End-stage osteoarthritis patients planning to undergo primary total hip arthroplasty
  7. BMI less than 40 kg/m2

Exclusion Criteria:

  1. BMI greater than or equal to 40 kg/m2.
  2. History of known bleeding disorder.
  3. History of medical co-morbidity that may result in poor wound healing (i.e. diabetes mellitus, peripheral vascular disease).
  4. Patients <18 or >80 years of age.
  5. Patients who are prisoners.
  6. Mentally unable to sign informed consent.
  7. Has an uncontrolled illness that, in the opinion of the investigator, is likely to cause the patient to be withdrawn from the trial or would otherwise interfere with interpreting the results of the study.

Sites / Locations

  • Cleveland Clinic

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

STRATAFIX GROUP

CONTROL GROUP

Arm Description

For the active arm of the study, wound closure will be performed similarly in 3 layers with the use of barbed equivalents at every layer: STRATIFIX symmetric PDS Plus #1 will be used to close the deep fascia and muscles . The subcutaneous fat layer will be then closed with simple interrupted knots using number 2-0 braided absorbable sutures (Vicryl), followed by closure of the subcutaneous layer using a number 2-0 monofilament absorbable suture with inverted interrupted knots (Monocryl, Ethicon; Johnson & Johnson) followed by the use of steri-strips and glue

For the control arm of the study, wound closure will be performed similarly in 3 layers with the use of vicryl to closure the deep fascia and muscles. The subcutaneous fat layer will be then closed with simple interrupted knots using number 2-0 braided absorbable sutures (Vicryl), followed by closure of the subcutaneous layer using a number 2-0 monofilament absorbable suture with inverted interrupted knots (Monocryl, Ethicon; Johnson & Johnson) followed by the use of steri-strips and glue

Outcomes

Primary Outcome Measures

Time to Close, Minutes
Time from first needle insertion to complete skin closure per protocol

Secondary Outcome Measures

Number of Participants With Wound Complications
Superficial wound infection, deep wound infection, periprosthetic joint infection, wound hematoma, and wound dehiscence.

Full Information

First Posted
September 14, 2017
Last Updated
October 29, 2020
Sponsor
The Cleveland Clinic
search

1. Study Identification

Unique Protocol Identification Number
NCT03285555
Brief Title
Prospective Randomized Trial of Stratafix vs. Vicryl in Total Hip Arthroplasty.
Official Title
Prospective Randomized Trial of Stratafix vs. Vicryl on Operating Room Time and Wound Closure Time in Total Hip Arthroplasty.
Study Type
Interventional

2. Study Status

Record Verification Date
October 2020
Overall Recruitment Status
Completed
Study Start Date
September 26, 2017 (Actual)
Primary Completion Date
June 30, 2019 (Actual)
Study Completion Date
August 31, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Cleveland Clinic

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
The STRATAFIX (Ethicon, Johnson and Johnson, Somerville, New Jersey) Knotless Tissue Control suture device is a barbed suture that uses anchor technology to securely engage with the soft tissues while also eliminating the need for knots. The anchors, or barbs, are pressed out of the device core or formed within the core in a geometric pattern and arranged in a tapered manner to allow the device to pass through tissue in the direction toward the needle during closure. These knotless tissue control devices are deployed using a continuous technique, which is anticipated to be faster and more cost-effective than interrupted suturing.
Detailed Description
Preclinical and biomechanical studies have demonstrated efficacy in cosmetic skin and deep tissue closures.[1], [2] In addition, barbed sutures have been shown to provide water-tight closure and wound strength comparable to or superior to closure with conventional sutures. Many comparative studies have been published contrasting barbed sutures to conventional closure techniques in multiple surgical fields. [3], [4] Various studies have evaluated the outcomes of different barbed suture devices, however there are no reports assessing the length of closure times using STRATAFIX (Ethicon, Johnson and Johnson, Somerville, New Jersey) Knotless Tissue Control Devices during deep closure in total hip arthroplasty. Stephens et al. [5] performed a prospective randomized study of 500 total knee arthroplasty patients who received either barbed suture (250) or conventional sutures (250) for deep closure of the surgical wound. The mean operating time was significantly shorter in the barbed group as compared to conventional group (64.3 vs 68.1 minutes, p=<0.001). In a study of 80 TKA (61 barbed, 19 conventional deep sutures) and 54 THA patients (37 barbed, 17 conventional deep sutures), Smith et al. [6] found significantly shorter closure time in the barbed suture group (16.78 vs. 26.5 minutes, p<0.001). One study reports one the use of Stratfix suture for intracorporeal suturing in myomectomy. Giampaolino et al. [7] performed a prospective randomized study on 47 patients and evaluated the mean operative time for laparoscopic posterior myomectomy using Stratafix or conventional suture for intracorporeal suturing. There was a significant decrease in mean operative time associated with use of Stratafix suture as compared to conventional suture (66.3 vs 73 minutes, p=0.005). This prospective randomized single-center study will examine the outcomes, mainly closure time, of deep closure during total hip arthroplasty using the STRATAFIX Symmetric PDS Plus (Ethicon, Johnson and Johnson, Somerville, New Jersey) barbed suture compared to interrupted VICRYL suture (Ethicon, Johnson and Johnson, Somerville, New Jersey).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Wound; Hip
Keywords
barbed suture, knoteless suture, closure, wound, time, total hip arthroplasty

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
STRATAFIX GROUP
Arm Type
Active Comparator
Arm Description
For the active arm of the study, wound closure will be performed similarly in 3 layers with the use of barbed equivalents at every layer: STRATIFIX symmetric PDS Plus #1 will be used to close the deep fascia and muscles . The subcutaneous fat layer will be then closed with simple interrupted knots using number 2-0 braided absorbable sutures (Vicryl), followed by closure of the subcutaneous layer using a number 2-0 monofilament absorbable suture with inverted interrupted knots (Monocryl, Ethicon; Johnson & Johnson) followed by the use of steri-strips and glue
Arm Title
CONTROL GROUP
Arm Type
Placebo Comparator
Arm Description
For the control arm of the study, wound closure will be performed similarly in 3 layers with the use of vicryl to closure the deep fascia and muscles. The subcutaneous fat layer will be then closed with simple interrupted knots using number 2-0 braided absorbable sutures (Vicryl), followed by closure of the subcutaneous layer using a number 2-0 monofilament absorbable suture with inverted interrupted knots (Monocryl, Ethicon; Johnson & Johnson) followed by the use of steri-strips and glue
Intervention Type
Device
Intervention Name(s)
STRATIFIX
Intervention Description
STRATIFIX symmetric PDS Plus; Stratifix knotless suture
Intervention Type
Device
Intervention Name(s)
VICRYL
Intervention Description
Vicryl #1
Primary Outcome Measure Information:
Title
Time to Close, Minutes
Description
Time from first needle insertion to complete skin closure per protocol
Time Frame
Day of surgery
Secondary Outcome Measure Information:
Title
Number of Participants With Wound Complications
Description
Superficial wound infection, deep wound infection, periprosthetic joint infection, wound hematoma, and wound dehiscence.
Time Frame
90 days postoperative

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Males and females, between the ages of 18 to 80 years at the time of signing the informed consent document. Understand and voluntarily sign an informed consent document prior to any study-related assessments/procedures are conducted. Able to adhere to the study visit schedule and other protocol requirements. Able to fluently speak and understand the local language If female, is non-pregnant (negative pregnancy test results at the baseline/randomization visit) and non-lactating. End-stage osteoarthritis patients planning to undergo primary total hip arthroplasty BMI less than 40 kg/m2 Exclusion Criteria: BMI greater than or equal to 40 kg/m2. History of known bleeding disorder. History of medical co-morbidity that may result in poor wound healing (i.e. diabetes mellitus, peripheral vascular disease). Patients <18 or >80 years of age. Patients who are prisoners. Mentally unable to sign informed consent. Has an uncontrolled illness that, in the opinion of the investigator, is likely to cause the patient to be withdrawn from the trial or would otherwise interfere with interpreting the results of the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Viktor Krebs
Organizational Affiliation
The Cleveland Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cleveland Clinic
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44195
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
No data will be shared with other researchers.
Citations:
PubMed Identifier
32188284
Citation
Sundaram K, Piuzzi NS, Klika AK, Molloy RM, Higuera-Rueda CA, Krebs VE, Mont MA. Barbed sutures reduce arthrotomy closure duration and suture utilisation compared to interrupted conventional sutures for primary total hip arthroplasty: a randomised controlled trial. Hip Int. 2021 Sep;31(5):582-588. doi: 10.1177/1120700020911891. Epub 2020 Mar 19.
Results Reference
derived

Learn more about this trial

Prospective Randomized Trial of Stratafix vs. Vicryl in Total Hip Arthroplasty.

We'll reach out to this number within 24 hrs